Back to search

Article

Is COVID-19 vaccination beneficial for tumor patients: a cross-sectional investigation in China

2024-09-03

Abstract excerpt

javascript:void(0) Tumor patients take a high risk of SARS-CoV-2 infection, high incidence of serious events, poor prognosis and high mortality in the coronavirus disease 2019 (COVID-19) epidemic, but there is still lack of supporting evidence that the COVID-19 vaccination is beneficial for tumor patients to encourage them to receive the vaccination. A cross-sectional study was conducted in Shantou, Chi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
beaab941-0ddc-5ab9-8f5d-20c718e4fa2f
DOI
10.22541/au.172538685.58050339/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Is COVID-19 vaccination beneficial for tumor patients: a cross-sectional investigation in ChinaDOI 10.22541/au.172538685.58050339/v1
Select a neighboring publication to make it the new centre.